UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 7.

Bauer, M; Karch, R; Neumann, F; Wagner, C C; Kletter, K; Müller, M; Löscher, W; Zeitlinger, M; Langer, O (2010). Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism, 30(3):510-515.

Wagner, C C; Biollaz, J; Zeitlinger, M; Buclin, T (2009). "Iatrogenicity cascade": doing harm by treating harm? Wiener Medizinische Wochenschrift, 159(1-2):53-57.

Wagner, C C; Bauer, M; Karch, R; Feurstein, T; Kopp, S; Chiba, P; Kletter, K; Löscher, W; Müller, M; Zeitlinger, M; Langer, O (2009). A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET. Journal of Nuclear Medicine, 50(12):1954-1961.

Bauer, M; Karch, R; Neumann, F; Abrahim, A; Wagner, C C; Kletter, K; Müller, M; Zeitlinger, M; Langer, O (2009). Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. European Journal of Clinical Pharmacology, 65(9):941-946.

Wagner, C C; Steiner, I; Zeitlinger, M (2009). Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption. International Journal of Clinical Pharmacology and Therapeutics, 47(3):178-186.

Zeitlinger, M; Wagner, C C; Heinisch, B (2009). Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective. Clinical Pharmacokinetics, 48(1):23-38.

Beer, J; Wagner, C C; Zeitlinger, M (2009). Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing. AAPS Journal, 11(1):1-12.

This list was generated on Fri Jul 21 05:35:05 2017 CEST.